Akso Health Group EBIT

The latest EBIT for AHG is $-27M as of March 2026. That compares with $3.9M in the prior-year period — down 794.7% year over year. That is below the Finance sector average of $350B. Investors often review this figure alongside Akso Health Group's historical trend and sector peers before judging valuation or financial health.

Over the past year, AHG's EBIT moved from $3.9M to $-27M — a 794.7% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Akso Health Group's operating scale or balance-sheet position.

Against Finance companies, AHG currently prints $-27M for EBIT, while the sector average sits near $350B. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Akso Health Group's growth, margins, and balance sheet.

A EBIT figure of $-27M for AHG is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Finance average is about $350B. Explore the charts below for those layers of context.

After noting AHG's EBIT ($-27M), review year-over-year change from $3.9M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.